Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1575 to 1624 of 6456 in total 
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
788\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hira-interacting protein 5 (cgi-33). [source:swissprot;acc:q9ums0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
138.705\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
132.538\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04653\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
loh1cr12. [source:refseq;acc:nm\_058169]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
230.087\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
220.579\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9.508\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
789\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein sa (p40) (34/67 kda laminin receptor) (colon carcinoma laminin-binding protein) (nem/1chd4) (multidrug resistance- associated protein mgr1-ag). [source:swissprot;acc:p08865]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.244\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.511\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04578\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
unr protein. [source:swissprot;acc:o75534]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
230.087\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
220.579\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9.508\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
790\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s21. [source:swissprot;acc:p35265]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.244\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.511\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04578\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
testis-specific protein tex28. [source:swissprot;acc:o15482]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.386\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.785\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9.399\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
791\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytoplasmic antiproteinase 3 (cap3) (cap-3) (protease inhibitor 9) (serpin b9). [source:swissprot;acc:p50453]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.244\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.511\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04578\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
similar to nuclear protein e3-3 orf1. [source:sptrembl;acc:q9bu61]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
212.386\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
221.785\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
9.399\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
792\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
a kindred of iglon. [source:refseq;acc:nm\_173808]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
maspin precursor (protease inhibitor 5). [source:swissprot;acc:p36952]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.244\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.511\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04578\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
793\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ankyrin-repeat family a protein 2 (rfxank-like 2). [source:swissprot;acc:q9h9e1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.386\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.785\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9.399\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
bomapin (protease inhibitor 10) (serpin b10). [source:swissprot;acc:p48595]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.244\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.511\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04578\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
794\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
inflammation-related g protein-coupled receptor ex33. [source:refseq;acc:nm\_020370]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.386\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.785\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9.399\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
plasminogen activator inhibitor-2 precursor (pai-2) (placental plasminogen activator inhibitor) (monocyte arg-serpin) (urokinase inhibitor). [source:swissprot;acc:p05120]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.244\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.511\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04578\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
795\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
palmitoyl-protein thioesterase 1 precursor (ec 3.1.2.22) (palmitoyl- protein hydrolase 1). [source:swissprot;acc:p50897]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.386\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.785\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9.399\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serpin b11. [source:swissprot;acc:q96p15]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.244\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.511\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04578\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
796\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-soluble nsf attachment protein (snap-beta) (n-ethylmaleimide- sensitive factor attachment protein, beta). [source:swissprot;acc:q9h115]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.386\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.785\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9.399\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
placental thrombin inhibitor (cytoplasmic antiproteinase) (cap) (protease inhibitor 6) (pi-6). [source:swissprot;acc:p35237]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
224.244\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
234.511\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04578\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
797\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytoplasmic antiproteinase 2 (cap2) (cap-2) (protease inhibitor 8) (serpin b8). [source:swissprot;acc:p50452]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
syntaxin 16 (syn16). [source:swissprot;acc:o14662]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
212.386\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
221.785\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
9.399\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
798\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
27 kda golgi snare protein (golgi snap receptor complex member 2) (membrin). [source:swissprot;acc:o14653]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
leukocyte elastase inhibitor (lei) (monocyte/neutrophil elastase inhibitor) (m/nei) (ei). [source:swissprot;acc:p30740]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.244\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.511\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04578\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
799\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
sequestosome 1; ubiquitin-binding protein p62; phosphotyrosine independent ligand for the lck sh2 domain p62. [source:refseq;acc:nm\_003900]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
221.965\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.404\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04501\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
syntaxin 1a (neuron-specific antigen hpc-1). [source:swissprot;acc:q16623]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
212.386\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
221.785\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
9.399\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
800\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-soluble nsf attachment protein (snap-alpha) (n-ethylmaleimide- sensitive factor attachment protein, alpha). [source:swissprot;acc:p54920]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nonspecific lipid-transfer protein, mitochondrial precursor (nsl-tp) (sterol carrier protein 2) (scp-2) (sterol carrier protein x) (scp-x) (scpx). [source:swissprot;acc:p22307]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.965\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.404\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04501\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
801\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adipocyte plasma membrane-associated protein (bscv protein). [source:swissprot;acc:q9hdc9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.386\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.785\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9.399\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
beta-catenin (pro2286). [source:swissprot;acc:p35222]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.445\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.894\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04445\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
802\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
synaptosomal-associated protein 29 (snap-29) (vesicle-membrane fusion protein snap-29) (soluble 29 kda nsf attachment protein). [source:swissprot;acc:o95721]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
212.386\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
221.785\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
9.399\vspace{3pt}}\\\cline{2-3}\cline{6-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
testis-specific protein tex28. [source:swissprot;acc:o15482]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04425\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
803\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to nuclear protein e3-3 orf1. [source:sptrembl;acc:q9bu61]\vspace{3pt}}&&&&\\\cline{2-3}\cline{6-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
syntaxin 1b. [source:swissprot;acc:q15531]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
9.399\vspace{3pt}}\\\cline{1-3}\cline{6-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
804\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
a kindred of iglon. [source:refseq;acc:nm\_173808]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
1.04425\vspace{3pt}}\\\cline{2-3}\cline{6-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma antigen p15 (melanoma-associated antigen recognized by t lymphocytes). [source:swissprot;acc:q13084]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
9.399\vspace{3pt}}\\\cline{1-3}\cline{6-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
805\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ankyrin-repeat family a protein 2 (rfxank-like 2). [source:swissprot;acc:q9h9e1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
1.04425\vspace{3pt}}\\\cline{2-3}\cline{6-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dna-binding protein rfxank (regulatory factor x subunit b) (rfx-b) (ankyrin repeat family a protein 1). [source:swissprot;acc:o14593]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
9.399\vspace{3pt}}\\\cline{1-3}\cline{6-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
806\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
inflammation-related g protein-coupled receptor ex33. [source:refseq;acc:nm\_020370]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
1.04425\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
maleylacetoacetate isomerase (ec 5.2.1.2) (maai) (glutathione s- transferase zeta 1) (ec 2.5.1.18) (gstz1-1). [source:swissprot;acc:o43708]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
267.447\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
276.773\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9.326\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
807\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
palmitoyl-protein thioesterase 1 precursor (ec 3.1.2.22) (palmitoyl- protein hydrolase 1). [source:swissprot;acc:p50897]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.386\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.785\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04425\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
trifunctional purine biosynthetic protein adenosine-3 [includes: phosphoribosylamine--glycine ligase (ec 6.3.4.13) (gars) (glycinamide ribonucleotide synthetase) (phosphoribosylglycinamide synthetase); phosphoribosylformylglycinamidine cyclo-ligase (ec 6.3.3.1) (airs) (phosphoribosyl-aminoimidazole synthetase) (air synthase); phosphoribosylglycinamide formyltransferase (ec 2.1.2.2) (gart) (gar transformylase) (5'-phosphoribosylglycinamide transformylase)]. [source:swissprot;acc:p22102]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.521\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
227.796\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9.275\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
808\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60 kda tat interactive protein (tip60) (hiv-1 tat interactive protein) (cpla(2) interacting protein). [source:swissprot;acc:q92993]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
223.186\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.912\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9.274\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
beta-soluble nsf attachment protein (snap-beta) (n-ethylmaleimide- sensitive factor attachment protein, beta). [source:swissprot;acc:q9h115]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.386\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.785\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04425\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
809\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
diphosphomevalonate decarboxylase (ec 4.1.1.33) (mevalonate pyrophosphate decarboxylase) (mevalonate (diphospho)decarboxylase). [source:swissprot;acc:p53602]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
233.298\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
242.571\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9.273\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
syntaxin 16 (syn16). [source:swissprot;acc:o14662]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
212.386\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
221.785\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04425\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
810\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
27 kda golgi snare protein (golgi snap receptor complex member 2) (membrin). [source:swissprot;acc:o14653]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
casein kinase ii, alpha chain (ck ii) (ec 2.7.1.37). [source:swissprot;acc:p19138]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
240.194\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
230.957\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
9.237\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
811\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
casein kinase ii, alpha' chain (ck ii) (ec 2.7.1.37). [source:swissprot;acc:p19784]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
syntaxin 1a (neuron-specific antigen hpc-1). [source:swissprot;acc:q16623]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
212.386\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
221.785\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04425\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
812\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-soluble nsf attachment protein (snap-alpha) (n-ethylmaleimide- sensitive factor attachment protein, alpha). [source:swissprot;acc:p54920]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
putatative 28 kda protein. [source:refseq;acc:nm\_020143]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
227.241\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
236.467\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9.226\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/